271 related articles for article (PubMed ID: 15609684)
21. Successful treatment of a patient with hairy cell leukemia and pentostatin-induced autoimmune thrombocytopenia with rituximab.
Hensel M; Ho AD
Am J Hematol; 2003 May; 73(1):37-40. PubMed ID: 12701118
[TBL] [Abstract][Full Text] [Related]
22. Should rituximab be used before or after splenectomy in patients with immune thrombocytopenic purpura?
Cooper N; Evangelista ML; Amadori S; Stasi R
Curr Opin Hematol; 2007 Nov; 14(6):642-6. PubMed ID: 17898569
[TBL] [Abstract][Full Text] [Related]
23. Successful use of rituximab in refractory idiopathic thrombocytopenic purpura in a patient with common variable immunodeficiency.
Al-Ahmad M; Al-Rasheed M; Al-Muhani A
J Investig Allergol Clin Immunol; 2010; 20(3):259-62. PubMed ID: 20635793
[TBL] [Abstract][Full Text] [Related]
24. [Acute disseminated encephalomyelitis during treatment for idiopathic thrombocytopenic purpura].
Hoshino T; Hatsumi N; Takada S; Sakura T; Sakurai A; Miyawaki S
Rinsho Ketsueki; 2008 Jul; 49(7):505-9. PubMed ID: 18709983
[TBL] [Abstract][Full Text] [Related]
25. Initial laboratory findings useful for predicting the diagnosis of idiopathic thrombocytopenic purpura.
Kuwana M; Okazaki Y; Satoh T; Asahi A; Kajihara M; Ikeda Y
Am J Med; 2005 Sep; 118(9):1026-33. PubMed ID: 16164890
[TBL] [Abstract][Full Text] [Related]
26. [Rituximab treatment of chronic idiopathic thrombocytopenic purpura. Results of a phase II study].
Meo P; Stipa E; La Presa M; Bianchi M; Di Giulio C; Stasi R; Amadori S
Recenti Prog Med; 2002; 93(7-8):421-7. PubMed ID: 12138687
[TBL] [Abstract][Full Text] [Related]
27. Rituximab treatment for symptomatic chronic ITP.
Tamminga RY; Bruin MC
Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):714-6. PubMed ID: 16933264
[TBL] [Abstract][Full Text] [Related]
28. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study.
Dierickx D; Verhoef G; Van Hoof A; Mineur P; Roest A; Triffet A; Kentos A; Pierre P; Boulet D; Bries G; Lê PQ; Janssens A; Delannoy A
J Intern Med; 2009 Nov; 266(5):484-91. PubMed ID: 19549092
[TBL] [Abstract][Full Text] [Related]
29. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
Rodeghiero F
Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
[TBL] [Abstract][Full Text] [Related]
30. [Idiopathic thrombocytopenic purpura].
Nomura S
Nihon Rinsho; 2003 Apr; 61(4):552-7. PubMed ID: 12718074
[TBL] [Abstract][Full Text] [Related]
31. Rituximab therapy for chronic and refractory immune thrombocytopenic purpura: a long-term follow-up analysis.
Garcia-Chavez J; Majluf-Cruz A; Montiel-Cervantes L; Esparza MG; Vela-Ojeda J;
Ann Hematol; 2007 Dec; 86(12):871-7. PubMed ID: 17874322
[TBL] [Abstract][Full Text] [Related]
32. [Clinical efficacy of lower dose rituximab for chronic refractory immune thrombocytopenic purpura].
Li Y; Wang XM; Mao M; Zhang XY; Fu L; Ai HM; Zhang LX
Zhonghua Xue Ye Xue Za Zhi; 2012 Mar; 33(3):204-6. PubMed ID: 22781608
[TBL] [Abstract][Full Text] [Related]
33. Anti-CD20 monoclonal antibody therapy in refractory immune thrombocytopenic purpura.
Delgado J; Bustos JG; Jimenez-Yuste V; Hernandez-Navarro F
Haematologica; 2002 Feb; 87(2):215-6. PubMed ID: 11836172
[TBL] [Abstract][Full Text] [Related]
34. Refractory autoimmune thrombocytopenic purpura: responses to treatment with a recombinant antibody to lymphocyte membrane antigen CD20 (rituximab).
Narang M; Penner JA; Williams D
Am J Hematol; 2003 Dec; 74(4):263-7. PubMed ID: 14635207
[TBL] [Abstract][Full Text] [Related]
35. Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura.
Zaja F; Battista ML; Pirrotta MT; Palmieri S; Montagna M; Vianelli N; Marin L; Cavallin M; Bocchia M; Defina M; Ippoliti M; Ferrara F; Patriarca F; Avanzini MA; Regazzi M; Baccarani M; Isola M; Soldano F; Fanin R
Haematologica; 2008 Jun; 93(6):930-3. PubMed ID: 18403395
[TBL] [Abstract][Full Text] [Related]
36. [Chronic myelomonocytic leukemia developed 7 years after the onset of idiopathic thrombocytopenic purpura like syndrome].
Sawanobori M; Nakagawa Y; Inoue Y; Suzuki K; Shinohara T; Takemura T
Rinsho Ketsueki; 1997 Mar; 38(3):222-7. PubMed ID: 9095662
[TBL] [Abstract][Full Text] [Related]
37. Rituximab in the treatment of idiopathic thrombocytopenic purpura (ITP).
Alasfoor K; Alrasheed M; Alsayegh F; Mousa SA
Ann Hematol; 2009 Mar; 88(3):239-43. PubMed ID: 18704420
[TBL] [Abstract][Full Text] [Related]
38. [Severe corticoid-refractory autoimmune thrombocytopenia associated with mixed connective tissue disease (Sharp's syndrome). Treatment with rituximab].
Rudolph SE; Kouba M; Hrdlicka P
Dtsch Med Wochenschr; 2009 Sep; 134(36):1734-8. PubMed ID: 19718594
[TBL] [Abstract][Full Text] [Related]
39. Rituximab is effective for selected patients with chronic steroid-refractory immune thrombocytopenic purpura.
Lalayanni C; Stavroyianni N; Saloum R; Tsompanakou A; Anagnostopoulos A
Hematology; 2004 Aug; 9(4):287-9. PubMed ID: 15621736
[TBL] [Abstract][Full Text] [Related]
40. Treatment of an infant with severe acute refractory immune thrombocytopenic purpura using combination therapy including rituximab.
Iesato K; Hatakeyama N; Yamamoto M; Hori T; Inazawa N; Tsutsumi H; Suzuki N
Pediatr Blood Cancer; 2009 Aug; 53(2):203-5. PubMed ID: 19301247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
